$2.84
3.73% yesterday
Nasdaq, Sep 04, 10:13 pm CET
ISIN
US34960Q1094
Symbol
FBIO

Fortress Biotech, Inc. Stock price

$2.84
+0.96 51.06% 1M
+1.31 85.62% 6M
+0.82 40.25% YTD
+0.97 51.87% 1Y
-13.21 82.31% 3Y
-53.26 94.94% 5Y
-35.86 92.66% 10Y
-147.16 98.11% 20Y
Nasdaq, Closing price Thu, Sep 04 2025
-0.11 3.73%
ISIN
US34960Q1094
Symbol
FBIO
Industry

Key metrics

Basic
Market capitalization
$87.8m
Enterprise Value
$67.2m
Net debt
positive
Cash
$74.4m
Shares outstanding
29.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.5 | 1.0
EV/Sales
1.1 | 0.8
EV/FCF
negative
P/B
2.0
Financial Health
Equity Ratio
15.8%
Return on Equity
-245.8%
ROCE
-105.7%
ROIC
-210.2%
Debt/Equity
1.2
Financials (TTM | estimate)
Revenue
$59.3m | $87.4m
EBITDA
$-102.7m | $-42.8m
EBIT
$-108.2m | $-101.7m
Net Income
$-24.1m | $-42.5m
Free Cash Flow
$-80.1m
Growth (TTM | estimate)
Revenue
-28.2% | 51.6%
EBITDA
-13.6% | 60.3%
EBIT
-13.8% | 8.6%
Net Income
51.5% | 24.0%
Free Cash Flow
23.0%
Margin (TTM | estimate)
Gross
70.9%
EBITDA
-173.2% | -49.0%
EBIT
-182.5%
Net
-40.6% | -48.6%
Free Cash Flow
-135.1%
More
EPS
$-0.8
FCF per Share
$-2.7
Short interest
11.9%
Employees
101
Rev per Employee
$570.0k
Show more

Is Fortress Biotech, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Fortress Biotech, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Fortress Biotech, Inc. forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Fortress Biotech, Inc. forecast:

Buy
89%
Hold
11%

Financial data from Fortress Biotech, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
59 59
28% 28%
100%
- Direct Costs 17 17
33% 33%
29%
42 42
26% 26%
71%
- Selling and Administrative Expenses 113 113
42% 42%
191%
- Research and Development Expense 31 31
56% 56%
53%
-103 -103
14% 14%
-173%
- Depreciation and Amortization 5.55 5.55
17% 17%
9%
EBIT (Operating Income) EBIT -108 -108
14% 14%
-183%
Net Profit -24 -24
51% 51%
-41%

In millions USD.

Don't miss a Thing! We will send you all news about Fortress Biotech, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortress Biotech, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-F...
Neutral
GlobeNewsWire
3 days ago
MIAMI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will ...
Neutral
GlobeNewsWire
18 days ago
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company primarily focused on selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chie...
More Fortress Biotech, Inc. News

Company Profile

Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.

Head office United States
CEO Lindsay Rosenwald
Employees 101
Founded 2006
Website www.fortressbiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today